Beneficial Effects of Preoperative Embolization on the Shamblin Type Ⅱ/Ⅲ Carotid Body Tumor Surgery
- VernacularTitle:术前经导管动脉栓塞对Shamblin Ⅱ/Ⅲ型颈动脉体瘤切除术的影响
- Author:
Xiang-guo KONG
1
;
Nan LI
2
;
Jian-yong YANG
2
;
Yong-hui HUANG
2
Author Information
1. Department of Radiology, Linyi People’s Hospital, Linyi, 260000
2. Department of Interventional Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
- Publication Type:Journal Article
- Keywords:
carotid body tumor;
preoperative transarterial embolization;
Shamblin classification;
surgical resection
- From:
Journal of Sun Yat-sen University(Medical Sciences)
2021;42(2):287-293
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the feasibility and efficacy of preoperative arterial embolization (Pre-TAE) on Ⅱ/Ⅲ carotid body tumors (CBTs) surgical resection. MethodsThis retrospective study reviewed 100 cases of CBTs in the First Affiliated Hospital, Sun Yat-sen University from Jan 2010 to Jan 2020, which underwent surgical resection for CBTs. According to whether receiving the pre-TAE, the patients were classified into the embolization group (EG) and non-embolization group (NEG). Tumor classification was performed as the Shamblin classification. The demographic, clinical features, and the operative and post-operative information about the patients were retrieved from the patient records. ResultsThe average tumor sizes were (Ⅱ: 40.91 vs. 37.32 mm, P > 0.05; Ⅲ: 63.58 vs. 65.75 mm, P > 0.05) for EG and NEG. The mean operative time (Ⅱ: 184.66 vs. 230.74 mins, P > 0.05; Ⅲ: 288.50 vs. 332.75 mins, P > 0.05) and intraoperative blood loss (Ⅱ: 100 vs. 100 mL, P > 0.05; Ⅲ: 750 vs. 1 000 mL, P > 0.05) were less in the EG patients. The incidence of revascularization required (Ⅱ: 28% vs. 32%, P > 0.05; Ⅲ: 58% vs. 100%, P > 0.05) and total complications (Ⅱ: 22% vs. 47%, P =0.026; Ⅲ: 50% vs. 75%, P > 0.05) were lower in the EG when compared with NEG. ConclusionsCBTs can be surgically resected safely and effectively with a need for pre-TAE. Resection patients who received pre-TAE had lower blood loss and shorter duration of operation. The rates of adverse events, revascularization were also lower for patients who had pre-TAE compared to those who did not. The larger the tumor size, the greater the surgical benefit of pre-TAE.